LycoRed Ltd.   Report issue

For profit Phase 2
Founded: Orange NJ United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2008
NCT00637858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

LycoRed Ltd.

Active Ingredients

Drugs in Phase 2 Trials (2)

prolycopene (2 trials)

tomato (1 trial)

Drugs in Other Trials (3)

lycopene (2 trials)

tomato oleoresin (3 trials)

vitamin e (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 2)

Prehypertension (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 5